Diadema-Partners-Lp

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
72
Total Value
201693517
Accession Number
0001892688-25-000116
Form Type
13F-HR
Manager Name
Diadema-Partners-Lp
Data Enrichment
99% identified
71 identified1 unidentified

Holdings

72 positions • $201.7M total value
Manager:
Search and click to pin securities to the top
Page 4 of 4
Unity Biotechnology, Inc.
Shares:346.9K
Value:$360.8K
% of Portfolio:0.2% ($360.8K/$201.7M)
IMMUNIC, INC.
Shares:317.8K
Value:$346.4K
% of Portfolio:0.2% ($346.4K/$201.7M)
Relay Therapeutics, Inc.
Shares:131.4K
Value:$344.3K
% of Portfolio:0.2% ($344.3K/$201.7M)
CAPRICOR THERAPEUTICS, INC.
Shares:30.3K
Value:$287.5K
% of Portfolio:0.1% ($287.5K/$201.7M)
ProQR Therapeutics N.V.
Shares:207.7K
Value:$276.2K
% of Portfolio:0.1% ($276.2K/$201.7M)
Eledon Pharmaceuticals, Inc.
Shares:64.6K
Value:$219.0K
% of Portfolio:0.1% ($219.0K/$201.7M)
aTYR PHARMA INC
Shares:54.7K
Value:$165.2K
% of Portfolio:0.1% ($165.2K/$201.7M)
Terns Pharmaceuticals, Inc.
Shares:56.1K
Value:$154.8K
% of Portfolio:0.1% ($154.8K/$201.7M)
Sagimet Biosciences Inc.
Shares:46.0K
Value:$150.0K
% of Portfolio:0.1% ($150.0K/$201.7M)
Candel Therapeutics, Inc.
Shares:25.0K
Value:$141.5K
% of Portfolio:0.1% ($141.5K/$201.7M)
Jazz Pharmaceuticals plc
Shares:100
Value:$12.4K
% of Portfolio:0.0% ($12.4K/$201.7M)
Vistagen Therapeutics, Inc.
Shares:200
Value:$500
% of Portfolio:0.0% ($500/$201.7M)